When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EPZM - Epizyme files U.S. application for tazemetostat for follicular lymphoma
Epizyme Inc.
Fresh off today's positive advisory committee vote backing tazemetostat for epithelioid sarcoma, Epizyme (NASDAQ:EPZM) files another marketing application with the FDA for the EZH2 inhibitor.
More news on: Epizyme, Inc., Healthcare stocks news, Stocks on the move,